These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23668999)

  • 21. Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus.
    Natsugoe S; Xiangming C; Matsumoto M; Okumura H; Nakashima S; Sakita H; Ishigami S; Baba M; Takao S; Aikou T
    Clin Cancer Res; 2002 Jun; 8(6):1838-42. PubMed ID: 12060625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma.
    Shinmei S; Sakamoto N; Goto K; Sentani K; Anami K; Hayashi T; Teishima J; Matsubara A; Oue N; Kitadai Y; Yasui W
    Int J Urol; 2013 May; 20(5):468-77. PubMed ID: 23050614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma.
    Ronkainen H; Hirvikoski P; Kauppila S; Vaarala MH
    Oncol Rep; 2011 Jan; 25(1):129-33. PubMed ID: 21109967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy.
    Harada K; Miyake H; Kusuda Y; Fujisawa M
    BJU Int; 2012 Dec; 110(11 Pt C):E1131-7. PubMed ID: 22712620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
    Liang ZL; Kang K; Yoon S; Huang SM; Lim JS; Kim JM; Lim JS; Lee HJ
    Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasohibin-1 is a new predictor of disease-free survival in operated patients with renal cell carcinoma.
    Kanomata N; Sato Y; Miyaji Y; Nagai A; Moriya T
    J Clin Pathol; 2013 Jul; 66(7):613-9. PubMed ID: 23543668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MUC1 expression is correlated with nuclear grade and tumor progression in pT1 renal clear cell carcinoma.
    Leroy X; Zerimech F; Zini L; Copin MC; Buisine MP; Gosselin B; Aubert JP; Porchet N
    Am J Clin Pathol; 2002 Jul; 118(1):47-51. PubMed ID: 12109855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
    Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
    Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear-cell renal cell carcinoma.
    Huang Y; Murakami T; Sano F; Kondo K; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
    Eur Urol; 2009 Oct; 56(4):690-8. PubMed ID: 18930582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PAI-1 expression and its regulation by promoter 4G/5G polymorphism in clear cell renal cell carcinoma.
    Choi JW; Lee JH; Park HS; Kim YS
    J Clin Pathol; 2011 Oct; 64(10):893-7. PubMed ID: 21725041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
    Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
    Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expression and prognostic value of alpha-, beta- and gamma-catenins in renal cell carcinoma.
    Aaltomaa S; Lipponen P; Kärjä V; Lundstedt S; Lappi J; Kosma VM
    Anticancer Res; 2004; 24(4):2407-13. PubMed ID: 15330191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer.
    Dahinden C; Ingold B; Wild P; Boysen G; Luu VD; Montani M; Kristiansen G; Sulser T; Bühlmann P; Moch H; Schraml P
    Clin Cancer Res; 2010 Jan; 16(1):88-98. PubMed ID: 20028743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma.
    Rogenhofer S; Kahl P; Mertens C; Hauser S; Hartmann W; Büttner R; Müller SC; von Ruecker A; Ellinger J
    BJU Int; 2012 Feb; 109(3):459-65. PubMed ID: 21810159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer.
    Xiangming C; Natsugoe S; Takao S; Hokita S; Ishigami S; Tanabe G; Baba M; Kuroshima K; Aikou T
    Clin Cancer Res; 2001 Feb; 7(2):277-82. PubMed ID: 11234879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intratumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma.
    Johnson TV; Ali S; Abbasi A; Kucuk O; Harris WB; Ogan K; Pattaras J; Nieh PT; Marshall FF; Osunkoya AO; Master VA
    J Urol; 2011 Oct; 186(4):1213-7. PubMed ID: 21849188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell carcinoma.
    Djordjevic G; Mozetic V; Mozetic DV; Licul V; Ilijas KM; Mustac E; Oguic R; Fuckar Z; Jonjic N
    Pathol Res Pract; 2007; 203(2):99-106. PubMed ID: 17270362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.